Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Revenue Breakdown and Options Chain

Gain deeper insights into company revenues with a detailed analysis of revenue sources.
Explore the updated Options feature, providing in-depth data, and a 3D viewing option.

Last Close
Apr 12 04:00PM ET
1.97
Dollar change
+0.08
Percentage change
4.23
%
Index- P/E- EPS (ttm)-1.21 Insider Own10.33% Shs Outstand2.91M Perf Week-3.86%
Market Cap5.59M Forward P/E- EPS next Y- Insider Trans6.62% Shs Float2.55M Perf Month17.26%
Income-3.70M PEG- EPS next Q- Inst Own5.65% Short Float2.41% Perf Quarter32.66%
Sales0.07M P/S79.93 EPS this Y- Inst Trans- Short Ratio0.46 Perf Half Y24.68%
Book/sh2.13 P/B0.93 EPS next Y- ROA-37.46% Short Interest0.06M Perf Year-18.09%
Cash/sh2.70 P/C0.73 EPS next 5Y- ROE-43.97% 52W Range1.22 - 3.05 Perf YTD36.81%
Dividend Est.- P/FCF- EPS past 5Y-4.01% ROI-59.91% 52W High-35.41% Beta-
Dividend TTM- Quick Ratio9.90 Sales past 5Y-19.76% Gross Margin-1116.97% 52W Low61.98% ATR (14)0.16
Dividend Ex-Date- Current Ratio9.90 EPS Y/Y TTM27.11% Oper. Margin-5347.41% RSI (14)56.56 Volatility13.78% 7.68%
Employees3 Debt/Eq0.00 Sales Y/Y TTM0.00% Profit Margin-5132.57% Recom1.00 Target Price10.00
Option/ShortNo / Yes LT Debt/Eq0.00 EPS Q/Q26.71% Payout- Rel Volume0.65 Prev Close1.89
Sales Surprise- EPS Surprise- Sales Q/Q0.00% Earnings- Avg Volume132.67K Price1.97
SMA202.90% SMA5015.45% SMA20014.83% Trades Volume85,585 Change4.23%
Apr-10-24 08:11AM
Apr-02-24 03:12PM
Mar-20-24 08:30AM
Mar-18-24 07:15AM
Feb-28-24 08:25AM
08:45AM Loading…
Feb-14-24 08:45AM
Feb-01-24 10:00AM
Jan-24-24 08:55AM
Jan-04-24 08:55AM
Dec-28-23 08:25AM
Nov-21-23 08:01AM
Nov-08-23 08:11AM
Oct-16-23 08:11AM
Oct-11-23 08:35AM
Sep-20-23 08:28AM
08:50AM Loading…
Sep-12-23 08:50AM
Aug-10-23 08:50AM
Aug-08-23 08:30AM
Jun-23-23 09:00AM
Jun-21-23 09:00AM
Jun-13-23 08:05AM
Jun-02-23 08:50AM
May-30-23 09:00AM
May-09-23 08:05AM
Apr-24-23 08:15AM
Apr-19-23 09:00AM
Mar-27-23 09:00AM
Mar-15-23 08:40AM
Feb-13-23 08:35AM
Feb-02-23 08:50AM
07:45AM Loading…
Jan-31-23 07:45AM
Jan-10-23 10:15AM
Dec-30-22 08:10AM
Dec-01-22 09:00AM
Nov-21-22 07:45AM
Nov-11-22 08:15AM
Oct-26-22 09:00AM
Oct-20-22 08:05AM
Oct-18-22 07:15AM
Oct-10-22 08:05AM
Oct-06-22 08:20AM
Oct-03-22 09:47AM
Sep-30-22 08:30AM
Sep-27-22 09:05AM
Sep-15-22 08:00AM
Jul-27-22 08:15AM
Jul-12-22 11:23AM
Jun-23-22 08:05AM
May-19-22 08:11AM
May-18-22 08:17AM
Apr-20-22 08:10AM
Mar-31-22 08:10AM
Silo Pharma, Inc. is a developmental stage biopharmaceutical company, which engages in the merging of traditional therapeutics with psychedelic research. It seeks to acquire and develop intellectual property or technology rights from universities and researchers to treat rare diseases, including the use of psychedelic drugs. The company was founded by Eric Weisblum on July 13, 2010 and is headquartered in Sarasota, FL.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Weisblum EricCEO and PresidentApr 05 '24Buy2.03400812175,432Apr 08 04:00 PM
Weisblum EricCEO and PresidentApr 04 '24Buy1.966001,176175,032Apr 08 04:00 PM
Weisblum EricCEO and PresidentApr 01 '24Buy1.911,1002,101174,432Apr 01 06:15 PM
Weisblum EricCEO and PresidentMar 28 '24Buy1.943,4086,612173,332Apr 01 06:15 PM
Weisblum EricCEO and PresidentDec 20 '23Buy1.61200322169,924Dec 21 04:13 PM
Weisblum EricCEO and PresidentDec 19 '23Buy1.63500815169,724Dec 21 04:13 PM
Weisblum EricCEO and PresidentDec 15 '23Buy1.529001,368169,224Dec 18 07:44 PM
Weisblum EricCEO and PresidentDec 14 '23Buy1.50200300168,324Dec 18 07:44 PM
Weisblum EricCEO and PresidentDec 07 '23Buy1.36324441168,124Dec 07 06:13 PM
Weisblum EricCEO and PresidentDec 06 '23Buy1.3476102167,800Dec 07 06:13 PM
Weisblum EricCEO and PresidentDec 05 '23Buy1.39600834167,724Dec 07 06:13 PM
Weisblum EricCEO and PresidentNov 30 '23Buy1.531,0001,530167,124Nov 30 09:10 PM
Weisblum EricCEO and PresidentNov 29 '23Buy1.571,0001,570166,124Nov 30 09:10 PM
Weisblum EricCEO and PresidentNov 27 '23Buy1.78250445165,124Nov 27 05:13 PM
Weisblum EricCEO and PresidentNov 22 '23Buy1.68400672164,874Nov 27 05:13 PM
Weisblum EricCEO and PresidentNov 21 '23Buy1.56300468164,474Nov 22 04:01 PM
Weisblum EricCEO and PresidentNov 20 '23Buy1.604,0506,480164,174Nov 22 04:01 PM
Weisblum EricCEO and PresidentNov 17 '23Buy1.541,8002,772160,124Nov 20 07:51 PM
Weisblum EricCEO and PresidentNov 16 '23Buy1.331,1001,463158,324Nov 20 07:51 PM
Ryweck Daniel E.Chief Financial OfficerMay 26 '23Buy2.131,0002,1265,000May 26 04:17 PM
Weisblum EricCEO and PresidentMay 18 '23Buy2.115001,054157,724May 18 04:15 PM
Weisblum EricCEO and PresidentMay 17 '23Buy2.062,5005,150157,224May 18 04:15 PM